This analysis revealed that patients with glioblastoma showed higher TSPO-PET signals (P < 0.05, FDR corrected) in 60 out of 123 brain regions of the contralateral hemisphere compared to healthy controls, pronounced in the mesio-temporal lobe (+14%, Fig. 1C and D). The gene discussed is TSPO; the disease is glioblastoma.